Evidence map›Paper›PMID 33262526›Full record

ArticleLeukemia2021

HDAC7 is a major contributor in the pathogenesis of infant t(4;11) proB acute lymphoblastic leukemia.

Oriol de Barrios, Alexandros Galaras, Juan L Trincado, Alba Azagra, Olga Collazo, Ainara Meler, Antonio Agraz-Doblas, Clara Bueno, Paola Ballerini, Giovanni Cazzaniga and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. HDAC7: a promising target in cancer.Frontiers in oncology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Oriol de BarriosLymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.
Alexandros GalarasBiomedical Sciences Research Center "Alexander Fleming", 16672, Vari, Greece.
Juan L TrincadoJosep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.ORCID http://orcid.org/0000-0001-5363-3774
Alba AzagraLymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-9097-1251
Olga CollazoLymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.
Ainara MelerLymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-0026-7325
Antonio Agraz-DoblasJosep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.
Clara BuenoJosep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.
Paola BalleriniDepartment of Pediatric Hematology, A. Trousseau Hospital, Paris, France.
Giovanni CazzanigaCentro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
Ronald W StamPrincess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4986-1656
Ignacio VarelaInstituto de Biomedicina y Biotecnología de Cantabria, Universidad de Cantabria-CSIC, Santander, Spain.ORCID http://orcid.org/0000-0002-0969-506X
Paola De LorenzoCentro Ricerca Tettamanti, Department of Pediatrics, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy.
Maria Grazia ValsecchiInterfant Trial Data Center, University of Milano-Bicocca, Monza, Italy.
Pantelis HatzisBiomedical Sciences Research Center "Alexander Fleming", 16672, Vari, Greece.ORCID http://orcid.org/0000-0001-5002-7728
Pablo MenéndezJosep Carreras Leukaemia Research Institute, School of Medicine, University of Barcelona, 08036, Barcelona, Spain.
Maribel ParraLymphocyte Development and Disease Group, Josep Carreras Leukaemia Research Institute (IJC), Ctra. de Can Ruti, Camí de les Escoles, s/n, 08916, Badalona, Barcelona, Spain. mparra@carrerasresearch.org.ORCID http://orcid.org/0000-0002-9072-5763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Histone DeacetylasesHumansInfantMyeloid-Lymphoid Leukemia ProteinPrecursor Cell Lymphoblastic Leukemia-LymphomaTranslocation, GeneticHDAC7 protein, humanHistone DeacetylasesMyeloid-Lymphoid Leukemia Protein

Identifiers

PMID33262526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.